September 30, 2016 The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates Turner MA, Davis JM, McCune S, Bax R, Portman RJ, Hudson, LD. “The International Neonatal Consortium Collaborating to Adv
September 12, 2016-September 13, 2016 Applying Regulatory Science to Neonates: Second Annual Scientific Workshop at European Medicines Agency (EMA) Date: September 12-13, 2016 Location: European Medicines Agency, Canary Wharf, London Sponsors: Critical Path Institute and Euro
August 19, 2016 Alzheimer’s disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset
July 14, 2016 Presentations from ADPKD Summit 2016: Addressing the need for Clinical Endpoints in ADPKD Critical Path Institute’s John-Michael Sauer presenting on fluid-based biomarkers and how they could be applied to help...
July 13, 2016 Critical Path Institute Announces Dr. Timothy R. Franson as Chair of C-Path’s Board of Directors July 13, 2016 Critical Path Institute Announces Dr. Timothy R. Franson as Chair of C-Path’s Board of Directors TUC
June 10, 2016 CAMD Access Statistics (through 6/7/16) Following CAMD’s May 2, 2016, announcement that it will integrate with the Global Alzheimer’s Association Interactive Network
June 6, 2016 C-Path and CDISC Announce Updated Therapeutic Area Standard for TB June 6, 2016 C-Path and CDISC Announce Updated Therapeutic Area Standard for TB TUCSON, Ariz., and AUSTIN, Texas –
May 26, 2016 Critical Path for Parkinson’s: Regulatory Path to Enable Targeting the Right Patients in Clinical Trials of Early Stages of Parkinson’s Disease